Sizz's Biotech Blog

Tracking the biotech sector

Google

Watch the latest videos on YouTube.com

January 9, 2008

Video & Headline of the Day

With the JPMorgan Healthcare Conference winding down, the news was a litter thinner today, but I found a couple of links worth taking a look it.

1) First up is an article from the Motley Fool, which takes a look at Sirtris' Diabetes pipeline

2) And here is a video from TheStreet.com TV, which profiles over-the-counter-traded biotech Derma Sciences

Posted by Sizz at 10:25 PM  

1 comments:

PENNY STOCK INVESTMENTS said...

Nice

January 30, 2014 at 1:54 PM  

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

 Subscribe in a reader

Enter your email address:

Delivered by FeedBurner

Seeking Alpha Certified

Check Out These Sites

  • Baby Biotechs
  • Biotechnical Currency
  • BioHealth Investor

Blog Archive

  • ▼  2008 (16)
    • ▼  January (16)
      • Cost of Capital Key to Valuation
      • What can we make of Amgen?
      • Gilead keeps impressing
      • Correction and Clarification to Tysabri article
      • Drug of the Week: Tysabri
      • Earnings Info Links
      • Another disappointing quarter for Genentech
      • Busy week comes to an end
      • Stock of the week: ViroPharma
      • Videos of the Day
      • FDA sets date for Theravance review
      • Video & Headline of the Day
      • Isis a big winner at JPMorgan Conference
      • Videos of the day
      • Stock to watch this week: Celgene
      • 2008 Re-Launch
  • ►  2007 (42)
    • ►  November (1)
    • ►  October (4)
    • ►  September (7)
    • ►  August (8)
    • ►  July (15)
    • ►  June (7)
Save This Page

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Add to Technorati Favorites

Powered by FeedBurner

StumbleUpon

Globe of Blogs

blog search directory

Directory of Finance/Business Blogs

Finance Blogs - Blog Top Sites

Web Log Directory

Submit your website to 20 Search Engines - FREE with ineedhits!

website stats

Notice of Disclosure

This blog is meant for information purposes only. I am not a registered financial analyst or advisor. All recommendations should be viewed only as my personal opinion. There are risks associated with investing such as significant financial loss. I cannot be held responsible for losses from investing. Please do your own research and consult with a registered professional before investing.